Viewing 0 reply threads
  • Author
    Posts
    • #18650

      The National MS Society has criticized Biogen for the $88,000 yearly list price it placed on Vumerity, and for repeated price increases with Tecfidera. Learn more here.

      Do you agree with the criticism Biogren is receiving about their pricing? What do you want them to know from your perspective as a patient or caregiver?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.
Copyright © 2017-2019 All rights reserved.

©2019 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account